Literature DB >> 1443758

The problem of transfusion-associated acquired immunodeficiency syndrome in Africa: a quantitative approach.

S J Heymann1, T F Brewer.   

Abstract

BACKGROUND: Transfusion-associated AIDS accounts for 10% of all cases of AIDS in Africa. The risk of HIV-1 contamination in transfusions continues to exist, even in countries where blood products are screened, because of limitations in test sensitivity, human error, and the window period. Furthermore, 30 African countries do not screen all of their blood products because of resource limitations.
METHODS: This study used decision analysis to compare the survival outcomes of severely anemic patients who are transfused with those of patients who are not transfused. Sensitivity analyses were performed.
RESULTS: When 5% of the blood supply is HIV-1 contaminated, every patient with a 6.6% or greater risk of dying from anemia should be transfused. Detailed results are provided for a wide range of HIV-1 contamination rates.
CONCLUSIONS: This study provides a method for developing and evaluating locality-specific transfusion guidelines. This method can be applied to other regions, including the United States, and to other diseases transmitted by blood products.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome--prevention and control; Africa; Behavior; Biology; Blood Supply; Decision Making; Developing Countries; Diseases; Economic Factors; Equipment And Supplies; Examinations And Diagnoses; Hematologic Tests; Hemic System; Hemoglobin Level; Hiv Infections--prevention and control; Laboratory Examinations And Diagnoses; Laboratory Procedures; Methodological Studies; Needs; Physiology; Recommendations; Risk Factors; Screening; Viral Diseases

Mesh:

Year:  1992        PMID: 1443758     DOI: 10.1016/s0196-6553(05)80199-3

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  4 in total

1.  Antifibrinolytic agents in traumatic hemorrhage.

Authors:  Tim Coats; Beverley Hunt; Ian Roberts; Haleema Shakur
Journal:  MedGenMed       Date:  2005-03-08

2.  Use of seroconversion panels to estimate delay in detection of anti-human immunodeficiency virus antibodies by enzyme-linked immunosorbent assay of pooled compared to singleton serum samples.

Authors:  Lena Novack; Noya Galai; Arieh Yaari; Mordechai Orgel; Eilat Shinar; Batia Sarov
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

3.  Agreement of decision analyses and subsequent clinical studies in infectious diseases.

Authors:  Joshua N Bress; Todd Hulgan; Jennifer A Lyon; Cecilia P Johnston; Harold Lehmann; Timothy R Sterling
Journal:  Am J Med       Date:  2007-05       Impact factor: 4.965

4.  Antifibrinolytic agents in traumatic haemorrhage.

Authors:  Tim Coats; Beverly Hunt; Ian Roberts; Haleema Shakur
Journal:  PLoS Med       Date:  2005-03-29       Impact factor: 11.069

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.